AstraZeneca shares fall 9% after heart drug trial falls short of target
Actions of AstraZeneca fell as much as 9% after a late-stage clinical trial for a heart disease drug failed to…
Ionis Pharmaceuticals Inc.
Novartis, Amgen and Eli Lilly's Lp(a) Drugs Aim to Prevent Heart Attacks
Pharma believes it has found the next frontier in heart attack prevention. Novartis, amgen and Eli Lilly are among drugmakers…
FDA Official Discusses UniQure Gene Therapy for Huntington's Disease
Thomas Fuller | SOPA Images | Light rocket | fake images UniQure needs to conduct another study to show that…